Debt Leverage

Showing 803 articles
Business

Bausch Health's Deep Discount: Market Overshoot or Justified Skepticism?

With shares languishing near $5.74, Bausch Health Companies (BHC) presents a stark valuation puzzle. While a standard DCF model suggests a staggering 91% undervaluation, the market's persistent sell-off reflects deep-seated concerns over the company's restructuring path and debt burden. We examine the numbers behind the divergence.

Business

ASGN Bets Big on AI with Quinnox Acquisition and $1B Buyback: Strategic Pivot or Risky Gamble?

ASGN reaffirms strong Q4 2025 revenue guidance and launches a dual-pronged strategy: a $290 million cash acquisition of AI-focused consultancy Quinnox and a $1 billion share repurchase program. The moves signal a decisive shift towards high-value AI and digital implementation services, even as the company navigates elevated debt and integration challenges under its new Everforth brand.

Business

Oxford Lane Capital Cuts Payout Amid Market Turbulence, NAV Takes a Hit

Oxford Lane Capital (OXLC) reported a challenging third fiscal quarter, marked by a significant drop in net asset value and investment income, prompting management to reduce its monthly distribution. The firm cited volatile conditions in the CLO and leveraged loan markets as key headwinds, while outlining a strategy to preserve capital for opportunistic investments.

Business

IBM Kicks Off 2026 Tech Bond Rush with Multi-Billion Dollar Offering

IBM has launched a multi-billion dollar, multi-currency bond sale, becoming one of the first major technology firms to access debt markets this year. The move, which comes amid strong investor appetite for tech credit, is seen as a bellwether for how the sector will fund growth initiatives in artificial intelligence and strategic acquisitions.